Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
30
NMPA:30
Drug Approvals
Cefalexin for Suspension
- Product Name
- 头孢氨苄干混悬剂
- Approval Number
- 国药准字H20249212
- Approval Date
- Oct 29, 2024
NMPA
Cefadroxil for Suspension
- Product Name
- 头孢羟氨苄干混悬剂
- Approval Number
- 国药准字H20247105
- Approval Date
- May 13, 2024
NMPA
Cefadroxil for Suspension
- Product Name
- 头孢羟氨苄干混悬剂
- Approval Number
- 国药准字H20247103
- Approval Date
- May 13, 2024
NMPA
Cefadroxil for Suspension
- Product Name
- 头孢羟氨苄干混悬剂
- Approval Number
- 国药准字H20247104
- Approval Date
- May 13, 2024
NMPA
Cefaclor Dispersible Tablets
- Product Name
- 头孢克洛分散片
- Approval Number
- 国药准字H20237158
- Approval Date
- Nov 20, 2023
NMPA
Sildenafil Citrate Orodispersible Tablet
- Product Name
- 枸橼酸西地那非口崩片
- Approval Number
- 国药准字H20234297
- Approval Date
- Oct 18, 2023
NMPA
Cefadroxil for Suspension
- Product Name
- 头孢羟氨苄干混悬剂
- Approval Number
- 国药准字H20233852
- Approval Date
- Jun 30, 2023
NMPA
Cefadroxil for Suspension
- Product Name
- 头孢羟氨苄干混悬剂
- Approval Number
- 国药准字H20233851
- Approval Date
- Jun 30, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found